These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35948211)

  • 1. Tamoxifen Retinopathy and Macular Telangiectasia Type 2: Similarities and Differences on Multimodal Retinal Imaging.
    Hess K; Park YJ; Kim HA; Holz FG; Charbel Issa P; Yoon YH; Tzaridis S
    Ophthalmol Retina; 2023 Feb; 7(2):101-110. PubMed ID: 35948211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2.
    Ayachit AG; Reddy LU; Joshi S; Ayachit GS
    Ophthalmol Retina; 2019 Jun; 3(6):516-522. PubMed ID: 31174674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OCT Angiography Findings of Tamoxifen Retinopathy: Similarity with Macular Telangiectasia Type 2.
    Lee S; Kim HA; Yoon YH
    Ophthalmol Retina; 2019 Aug; 3(8):681-689. PubMed ID: 31068263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography.
    Pauleikhoff D; Gunnemann F; Book M; Rothaus K
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1381-1392. PubMed ID: 31093765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal Imaging of Macular Telangiectasia Type 2: Focus on Vascular Changes Using Optical Coherence Tomography Angiography.
    Toto L; Di Antonio L; Mastropasqua R; Mattei PA; Carpineto P; Borrelli E; Rispoli M; Lumbroso B; Mastropasqua L
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT268-76. PubMed ID: 27409482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Effects of Hormone Therapy in Type 2 Idiopathic Macular Telangiectasia.
    Wolf-Schnurrbusch UEK; Leung I; Sallo FB; Clemons TE; Chew EY; Bird AC; Peto T;
    Ophthalmic Res; 2018; 60(1):38-42. PubMed ID: 28903123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, and the MacTel Area: MacTel Project Report Number 8.
    Heeren TFC; Chew EY; Clemons T; Fruttiger M; Balaskas K; Schwartz R; Egan CA; Charbel Issa P;
    Ophthalmology; 2020 Nov; 127(11):1539-1548. PubMed ID: 32586743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density.
    Chin EK; Kim DY; Hunter AA; Pilli S; Wilson M; Zawadzki RJ; Werner JS; Park SS
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4459-70. PubMed ID: 23716628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EARLY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS TO CONFIRM FELLOW EYE CHANGES IN ASYMMETRIC TYPE-2 MACULAR TELANGIECTASIA: A Case-Control Study (India Macular Telangiectasia Report 1).
    Alex D; Giridhar A; Gopalakrishnan M; Manayath G; Amar S; Raman R; Sreenivasan R; Ayachit A; Sivaprasad S
    Retina; 2021 Mar; 41(3):471-479. PubMed ID: 32804830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OUTER FOVEAL DEFECTS IN TYPE-2 MACULAR TELANGIECTASIA.
    Chandran K; Giridhar A; Gayathri MS; Antison M; Gopalakrishnan M; Sivaprasad S
    Retina; 2023 Jan; 43(1):111-119. PubMed ID: 36542082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fundus Autofluorescence Imaging in Macular Telangiectasia Type 2: MacTel Study Report Number 9.
    Pauleikhoff L; Heeren TFC; Gliem M; Lim E; Pauleikhoff D; Holz FG; Clemons T; Balaskas K; ; Egan CA; Charbel Issa P
    Am J Ophthalmol; 2021 Aug; 228():27-34. PubMed ID: 33775659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHARACTERIZING RETINAL-CHOROIDAL ANASTOMOSIS IN MACULAR TELANGIECTASIA TYPE 2 WITH OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
    Breazzano MP; Yannuzzi LA; Spaide RF
    Retina; 2020 Jan; 40(1):92-98. PubMed ID: 31246676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OCT of Outer Retinal Hyperreflectivity, Neovascularization, and Pigment in Macular Telangiectasia Type 2.
    Krivosic V; Lavia C; Aubineau A; Tadayoni R; Gaudric A
    Ophthalmol Retina; 2021 Jun; 5(6):562-570. PubMed ID: 32956858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of retinal microvascular changes in macular telangiectasia type 2 using optical coherence tomography angiography.
    Park YG; Park YH
    PLoS One; 2020; 15(4):e0232255. PubMed ID: 32348375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of multicolor imaging, its component channels, and fundus autofluorescence in describing macular telangiectasia type-2 (MacTel) lesion characteristics.
    Chandran K; Giridhar A; Desai S; Gopalakrishnan M; Indu VP; Sivaprasad S
    Indian J Ophthalmol; 2024 Jan; 72(Suppl 1):S125-S134. PubMed ID: 38131554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year follow-up of optical coherence tomography angiography microvascular findings: macular telangiectasia type 2 versus tamoxifen retinopathy.
    Park YJ; Lee S; Yoon YH
    Graefes Arch Clin Exp Ophthalmol; 2022 Nov; 260(11):3479-3488. PubMed ID: 35536356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen retinopathy and macular telangiectasia: A comparative case series.
    Venkatesh R; Sharief S; Jayadev C; Reddy NG; Mangla R; Agrawal R; Yadav NK; Chhablani J
    Eur J Ophthalmol; 2022 Nov; ():11206721221142637. PubMed ID: 36437624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MACULAR TELANGIECTASIA TYPE 2: Acircularity Index and Quantitative Assessment of Foveal Avascular Zone Using Optical Coherence Tomography Angiography.
    Ersoz MG; Hocaoglu M; Sayman Muslubas I; Arf S; Karacorlu M
    Retina; 2020 Jun; 40(6):1132-1139. PubMed ID: 30893277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of macular pigments in macular telangiectasia type 2 and correlation with optical coherence tomography characteristics and visual acuity.
    Srinivasan R; Teussink MM; Sloan KR; Bharat RPK; Narayanan R; Raman R
    BMC Ophthalmol; 2022 Jun; 22(1):264. PubMed ID: 35698056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multilayer Retinal Correspondence of the Structural and Vascular Anomalies in Eyes With Early Macular Telangiectasia Type 2.
    Krivosic V; Dobbels Z; Duliere C; Zureik A; Tadayoni R; Gaudric A
    Invest Ophthalmol Vis Sci; 2024 Sep; 65(11):24. PubMed ID: 39283616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.